Melodi Health Secures $10.75 Million in Series A Funding and Launches Pivotal ARIA Trial for Innovative Breast Reconstruction Device

Melodi Health, a trailblazer in breast reconstruction technology, has achieved two significant milestones: the successful close of a $10.75 million Series A funding round and the commencement of the pivotal “ARIA” investigational device exemption (IDE) trial. The company’s efforts are centered on its groundbreaking device, the Melodi Matrix™, aimed at addressing post-surgical complications in breast…

Read More

APMIC Ventures into U.S. Market with Cutting-Edge AI Solution: “CaiGunn”

Pioneering Taiwanese AI firm APMIC is set to make waves in the U.S. market with the introduction of its advanced large language model (LLM), “CaiGunn.” As the sole Taiwanese independent software vendor endorsed by NVIDIA, APMIC is primed to elevate global enterprise AI solutions. This expansion reflects APMIC’s commitment to democratizing AI and equipping businesses…

Read More

ThinkCyte Secures $32 Million in Series C Funding to Expand Global Reach of VisionSort™, Revolutionary AI-Driven Cell Sorting Technology

ThinkCyte Inc., a trailblazer in innovative cell analysis technology, has announced a significant milestone in its growth journey. The company has successfully closed a Series C funding round, raising $32 million in total, which includes an extension round of $15 million. This impressive funding round was spearheaded by the Japan Green Investment Corp. for Carbon…

Read More